<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01379040</url>
  </required_header>
  <id_info>
    <org_study_id>CF1</org_study_id>
    <nct_id>NCT01379040</nct_id>
  </id_info>
  <brief_title>Volatile Organic Compounds in Cystic Fibrosis</brief_title>
  <acronym>VOCCF</acronym>
  <official_title>Detection of Pulmonary Colonization in Cystic Fibrosis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Landon Pediatric Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Landon Pediatric Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This experiment is designed to test the effectiveness of a new electronic nose device, which
      allows a non-invasive breath test for markers of lower respiratory tract infection, which may
      predict the probability of bacterial organisms in the lower respiratory tract. It consists
      of:

        -  A breath collection apparatus for collection of volatile organic compounds in breath
           onto a sorbent trap and Tedlar bag, as well as for the collection of a separate sample
           of room air.

        -  Analysis of the volatile organic compounds in breath and room air by short acoustic
           wave/gas chromatography.

        -  Interpretation of the volatile organic compounds with a proprietary algorithm in order
           to predict the probability of lower respiratory tract colonization and infection.

      This study will test the hypothesis that the investigators can identify the presence of
      Pseudomonas aeruginosa by sampling the &quot;head space&quot; above culture media of sputum provided by
      patients with cystic fibrosis. This study will test the additional hypothesis that the
      investigators can identify the presence of Pseudomonas aeruginosa by sampling exhaled breath
      from the patient providing the sputum.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bacterial Identification</measure>
    <time_frame>six months</time_frame>
    <description>Patient's provided breath samples and sputum for culture. Bacterial identification by indices was achieved</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Pseudomonas Aeruginosa</condition>
  <arm_group>
    <arm_group_label>Cystic Fibrosis Patients</arm_group_label>
    <description>Patients with Cystic Fibrosis, some having Pseudomonas aeruginosa, some not.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cystic Fibrosis patients</intervention_name>
    <arm_group_label>Cystic Fibrosis Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from Dr. Landon's primary care clinic.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Cystic Fibrosis

          -  Must be able to give breath and sputum samples

        Exclusion Criteria:

          -  Heavy smoker

          -  Inability to regularly give breath and sputum samples

          -  History of additional pulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pediatric Diagnostic Center</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>http://www.beehive.co.jp/est/samplePDF/CysticFibrosis.pdf</citation>
  </results_reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2011</study_first_submitted>
  <study_first_submitted_qc>June 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2011</study_first_posted>
  <last_update_submitted>August 12, 2014</last_update_submitted>
  <last_update_submitted_qc>August 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Landon Pediatric Foundation</investigator_affiliation>
    <investigator_full_name>Chris Landon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Pseudomonas aeruginosa</keyword>
  <keyword>Volatile Organic Compounds</keyword>
  <keyword>Electronic nose</keyword>
  <keyword>Gas Chromatography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Pseudomonas Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

